85960315 - RHEUMASTRAT

Information

• Trademark
• 85960315

• Source

• Serial Number

  85960315

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  June 14, 2013
  11 years ago

• Transaction Date

  July 30, 2015
  9 years ago

• Status Date

  July 29, 2015
  9 years ago

• Published for Opposition Date

  June 10, 2014
  10 years ago

• Location Date

  March 12, 2015
  9 years ago

• Status Code

  731

• Current Location

  INTENT TO USE SECTION

  Employee Name

  KENEALY, NATALIE LANGF

• Attorney Docket Number

  FIFW.T0104US

  Attorney Name

  Alicia Morris Groos

  Law Office Assigned Location Code

  L40

• Owners

  • RANDOX LABORATORIES, LTD.

Case File Statements

• GS0011: Chemicals used in industry, science, photography, agriculture, horticulture and forestry; chemical reagents other than for medical purpose; enzymes for scientific and research purposes and proteins for industrial use; diagnostic preparations for scientific purposes; clinical diagnostic preparations or reagents other than for medical use; diagnostic preparations, namely, diagnostic scanning agents; diagnostic testing materials, namely, diagnostic preparations, reagents and contrast media other than for medical use; chemical reagents for use in diagnostic tests, other than for medical use; clinical diagnostic reagents for laboratory in vitro and/or vivo use
• GS0051: Pharmaceutical preparations for the treatment of rheumatoid arthritis, and pharmaceutical substances, namely, for the prediction of response to anti-Tumor Necrosis Factor, also known as TNF, therapies and sanitary preparations for the prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic preparations and substances for medical use; diagnostic kits consisting primarily of multiplex polymerase chain reaction reagents and biochip array reagents; clinical diagnostic preparations for medical use; clinical diagnostic reagents for medical in vitro and/or vivo use; diagnostic scanning agents for in-vivo use used for the prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic testing materials, namely, diagnostic preparations, reagents and contrast media for medical use; clinical medical reagents; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for medical purposes; parts and fittings for all the aforesaid goods, namely, multiplex polymerase chain reaction reagents and biochip array reagents; chemical reagents for medical purposes; enzymes for medical purposes
• GS0421: Scientific and technological services, namely, research and design in the field of rheumatoid arthritis; medical research services; clinical research services, namely, conducting clinical trials for others; biological research; conducting clinical trials for others, namely, analysis, management and reporting of clinical data; consulting services in the field of quality assessment services for clinical laboratories; chemical research; chemical laboratory services; chemical analysis; scientific and medical laboratory services for analytical testing; medical laboratory services; biochemistry research and consultant advisory services; conducting clinical trials for others; providing computer aided diagnostic testing services for predicting response to anti-Tumor Necrosis Factor therapies for others in the field of science and research related thereto; scientific and technological services, namely, development of test equipment for medical apparatus for others; advice, information and consultancy services relating to all the aforesaid services
• GS0441: Medical services; providing health advice and information services; medical care services; health clinic services; healthcare services, namely, geriatric health care, physical therapy; medical health assessment services, namely, providing prediction of response to anti-Tumor Necrosis Factor therapies; diagnostic health screening services in the field of rheumatoid arthritis ; medical testing for prediction of response to therapy; medical diagnostic testing services; genetic testing for medical for medical purposes; medical clinics; advice, information and consultancy services for all of the aforesaid services

Case File Event Statements

• 7/30/2015 - 9 years ago

  32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/29/2015 - 9 years ago

  31 - EXTENSION 2 GRANTED Type: EX2G

• 7/22/2015 - 9 years ago

  30 - EXTENSION 2 FILED Type: EXT2

• 7/22/2015 - 9 years ago

  29 - TEAS EXTENSION RECEIVED Type: EEXT

• 3/17/2015 - 9 years ago

  28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/16/2015 - 9 years ago

  27 - EXTENSION 1 GRANTED Type: EX1G

• 1/27/2015 - 9 years ago

  26 - EXTENSION 1 FILED Type: EXT1

• 3/12/2015 - 9 years ago

  25 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 1/27/2015 - 9 years ago

  24 - TEAS EXTENSION RECEIVED Type: EEXT

• 8/5/2014 - 10 years ago

  23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/10/2014 - 10 years ago

  22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/10/2014 - 10 years ago

  21 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/21/2014 - 10 years ago

  20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/7/2014 - 10 years ago

  19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 5/7/2014 - 10 years ago

  18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/6/2014 - 10 years ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/6/2014 - 10 years ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/6/2014 - 10 years ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/6/2014 - 10 years ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/1/2014 - 10 years ago

  13 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 5/1/2014 - 10 years ago

  12 - FINAL REFUSAL E-MAILED Type: GNFR

• 5/1/2014 - 10 years ago

  11 - FINAL REFUSAL WRITTEN Type: CNFR

• 4/8/2014 - 10 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/8/2014 - 10 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/4/2014 - 10 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 3/25/2014 - 10 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/26/2013 - 11 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/26/2013 - 11 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/26/2013 - 11 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/24/2013 - 11 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/24/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 6/18/2013 - 11 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP